Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al

Ann Rheum Dis. 2022 Oct;81(10):e199. doi: 10.1136/annrheumdis-2020-218806. Epub 2020 Aug 27.

Silvia Piantoni^{1

2}, Enrico Colombo^{3

4}, Roberto Furloni^{3

4}, Laura Andreoli^{5

2}, Antonio Brucato⁶, Massimo Imazio⁷, Paolo Airó^#⁵, Mirko Scarsi^#^{3

4}

¹ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy slv.piantoni@gmail.com.
² Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
³ Internal Medicine Department, ASST Valcamonica, Esine (Brescia), Italy.
⁴ COVID Unit, ASST Valcamonica, Esine (Brescia), Italy.
⁵ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.
⁶ Department of Biomedical and Clinical Sciences "Sacco", University of Milano, Ospedale Fatebenefratelli, Milano, Italy.
⁷ University Cardiology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

^# Contributed equally.

No abstract available

Keywords: anti-inflammatory agents; antirheumatic agents; inflammation; non-steroidal.

Publication types